Colgate-Palmolive (CL) Shares Sold by Bradley Foster & Sargent Inc. CT

Bradley Foster & Sargent Inc. CT trimmed its stake in Colgate-Palmolive (NYSE:CL) by 3.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 110,420 shares of the company’s stock after selling 3,642 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in Colgate-Palmolive were worth $7,393,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of CL. CSat Investment Advisory L.P. bought a new position in Colgate-Palmolive during the second quarter valued at approximately $111,000. Price Capital Management Inc. bought a new position in Colgate-Palmolive during the third quarter valued at approximately $121,000. O Brien Wealth Partners LLC bought a new position in Colgate-Palmolive during the third quarter valued at approximately $123,000. Bridgeworth LLC bought a new position in Colgate-Palmolive during the second quarter valued at approximately $120,000. Finally, Fort L.P. bought a new position in Colgate-Palmolive during the second quarter valued at approximately $123,000. Institutional investors own 75.17% of the company’s stock.

In related news, VP Philip G. Shotts sold 462 shares of the firm’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total value of $30,977.10. Following the completion of the sale, the vice president now owns 41,250 shares of the company’s stock, valued at $2,765,812.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Dennis J. Hickey sold 120,000 shares of the firm’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $65.72, for a total value of $7,886,400.00. Following the completion of the sale, the insider now directly owns 202,414 shares of the company’s stock, valued at approximately $13,302,648.08. The disclosure for this sale can be found here. Insiders sold 169,585 shares of company stock valued at $11,132,140 in the last ninety days. 1.02% of the stock is currently owned by insiders.

CL has been the topic of several recent analyst reports. Barclays set a $64.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Monday, July 30th. Wells Fargo & Co cut their target price on shares of Colgate-Palmolive from $62.00 to $58.00 and set a “market perform” rating on the stock in a report on Monday. UBS Group set a $71.00 target price on shares of Colgate-Palmolive and gave the stock a “buy” rating in a report on Wednesday, October 17th. Atlantic Securities initiated coverage on shares of Colgate-Palmolive in a report on Thursday, September 20th. They issued a “neutral” rating and a $71.00 target price on the stock. Finally, Macquarie cut shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $74.00 to $65.00 in a report on Monday, July 30th. Four investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $68.06.

Shares of Colgate-Palmolive stock opened at $59.55 on Thursday. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $77.91. The company has a market capitalization of $52.20 billion, a PE ratio of 20.75, a PEG ratio of 2.96 and a beta of 0.72. The company has a current ratio of 1.11, a quick ratio of 0.28 and a debt-to-equity ratio of 64.85.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 26th. The company reported $0.72 EPS for the quarter, hitting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. The company had revenue of $3.85 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same quarter last year, the firm posted $0.73 earnings per share. The firm’s revenue was down 3.2% on a year-over-year basis. As a group, analysts predict that Colgate-Palmolive will post 2.96 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 15th. Investors of record on Friday, October 19th will be paid a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date of this dividend is Thursday, October 18th. Colgate-Palmolive’s payout ratio is 58.54%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

See Also: What is a Fiduciary?

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply